Company intelligence / Profile preview

CoreMap

Colchester, Vermont, USAcoremapmedical.com ↗

Ownership: Private
Employees: ~37
Development stage: Preclinical

Overview

CoreMap has developed a next-generation electrophysiology mapping system using patented high-density micro-electrode arrays and advanced algorithms to identify the sources ("drivers") of atrial fibrillation. Their technology enables more precise, patient-specific ablation strategies. Early clinical studies have shown strong safety and acute effectiveness; pivotal trials are underway to demonstrate superiority over standard-of-care approaches for persistent AF patients.

Therapeutic areas: Cardiovascular
Modalities: DeviceDiagnostic technology (specifically high-density mapping catheter and software)
Industry: Physiological Monitoring

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.

Beyond the preview

Go deeper on CoreMap.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CoreMap.

Explore the full profile